Vitamin B6 suppresses serine protease inhibitor 3 expression in the colon of rats and in TNF-α-stimulated HT-29 cells

Molecular Nutrition and Food Research

Volumn 55, Issue 4, 2011, Pages 635-643

  Yanaka, Noriyuki ^a   Ohata, Tomomi ^a   Toya, Keigo ^a   Kanda, Mayumi ^a   Hirata, Atsuko ^a   Kato, Norihisa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Colon; NF B; Serine protease inhibitor; Ubiquitin; Vitamin B6

Indexed keywords

ACUTE PHASE PROTEIN; ANTINEOPLASTIC AGENT; I KAPPA B; MESSENGER RNA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PYRIDOXINE; RECOMBINANT PROTEIN; SERINE PROTEINASE INHIBITOR; SERPINA3 PROTEIN, HUMAN; SERPINA3N PROTEIN, RAT; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL STRAIN HT29; COLON; COLON TUMOR; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; PATHOPHYSIOLOGY; PYRIDOXINE DEFICIENCY; RAT; UBIQUITINATION; WISTAR RAT;

ACUTE-PHASE PROTEINS; ANIMALS; ANTICARCINOGENIC AGENTS; COLON; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION; HT29 CELLS; HUMANS; I-KAPPA B PROTEINS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; RNA, MESSENGER; SERPINS; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINATION; VITAMIN B 6; VITAMIN B 6 DEFICIENCY;

ANIMALIA; RATTUS;

EID: 79953331585     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000282     Document Type: Article

References (41)

1. Trakatellis, A. C., Axelrod, A. E., Effect of pyridoxine deficiency on nucleic acid and metabolism in the rat. Biochem. J. 1965, 95, 344-349.
2. Moon, W. H., Kirksev, A., Cellular growth during prenatal and early postnatal periods in progeny of pyridoxine-deficient rats. J. Nutr. 1973, 103, 123-133.
3. Moshfegh, A. J., Goldman, J. D., Cleveland, L. E., What We Eat in America, NHANES 2001-2002: Usual Nutrient Intakes from Food Compared to Dietary Reference Intakes. US Department of Agriculture, Agricultural Research Service, Beltsville, MD 2005.
4. Roubenoff, R., Roubenoff, R. A., Selhub, J., Nadeau, M. R. et al., Abnormal vitamin B6 status in rheumatoid cachexia. Association with spontaneous tumor necrosis factor α production and markers of inflammation. Arthritis Rheum. 1995, 38, 105-109.
5. Woolf, K., Manore, M. M., Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis. J. Am. Diet. Assoc. 2008, 108, 443-453.
6. Reynolds, R. D., Natta, C. L., Depressed plasma pyridoxal phosphate concentrations in adult asthmatics. Am. J. Clin. Nutr. 1985, 41, 684-688.
7. Shen, J., Lai, C. Q., Mattei, J., Ordovas, J. M., Tucker, K. L., Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am. J. Clin. Nutr. 2010, 91, 337-342.
8. Chiang, E. P., Smith, D. E., Selhub, J., Dallal, G. et al., Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res. Ther. 2005, 7, R1254-R1262.
9. Chiang, E. P., Selhub, J., Bagley, P. J., Dallal, G., Roubenoff, R., Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. Arthritis Res. Ther. 2005, 7, R1404-R1411.
10. Chiang, E. P., Bagley, P. J., Selhub, J., Nadeau, M., Roubenoff, R., Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am. J. Med. 2003, 114, 283-287.
11. Komatsu, S. I., Watanabe, H., Oka, T., Tsuge, H. et al., Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J. Nutr. 2001, 131, 2204-2207.
12. Slattery, M. L., Potter, J. D., Coates, A., Ma, K. N. et al., Plant foods and colon cancer: an assessment of specific foods and their related nutrients (United States). Cancer Causes Control 1997, 8, 575-590.
13. Jansen, M. C., Bueno-de-Mesquita, H. B., Buzina, R., Fidanza, F. et al., Dietary fiber and plant foods in relation to colorectal cancer mortality: the Seven Countries Study. Int. J. Cancer 1999, 81, 174-179.
14. Matsubara, K., Mori, M., Matsuura, Y., Kato, N., Pyridoxal 5'-phosphate and pyridoxal inhibit angiogenesis in serum-free rat aortic ring assay. Int. J. Mol. Med. 2001, 8, 505-508.
15. Matsubara, K., Komatsu, S., Oka, T., Kato, N., Vitamin B6-mediated suppression of colon tumorigenesis, cell proliferation, and angiogenesis (review). J. Nutr. Biochem. 2003, 14, 246-250.
16. Oka, T., Sugitatsu, H., Nordin, H., Thakur, M. K. et al., Pyridoxal 5'-phosphate inhibits DNA binding of HNF1. Biochim. Biophys. Acta 2001, 1568, 189-196.
17. Allgood, V. E., Powell-Oliver, F. E., Cidlowski, J. A., Vitamin B6 influences glucocorticoid receptor-dependent gene expression. J. Biol. Chem. 1990, 265, 12424-12433.
18. Allgood, V. E., Cidlowski, J. A., Vitamin B6 modulates transcriptional activation by multiple members of the steroid hormone receptor superfamily. J. Biol. Chem. 1992, 267, 3819-3824.
19. Huq, M. D., Tsai, N. P., Lin, Y. P., Higgins, L., Wei, L. N., Vitamin B6 conjugation to nuclear corepressor RIP140 and its role in gene regulation. Nat. Chem. Biol. 2007, 3, 161-165.
20. Watanabe, K., Kawamori, T., Nakatsugi, S., Wakabayashi, K., COX-2 and iNOS, good targets for chemoprevention of colon cancer. Biofactors 2000, 12, 129-133.
21. Reeves, G. P., Nielsen, H. F., Fahey, C. G., Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939-1951.
22. Tsuge, H., Determination of vitamin B6 vitamers and metabolites in a biological sample. Meth. Enzymol. 1997, 280, 3-12.
23. Yanaka, N., Koyama, T. A., Komatsu, S., Nakamura, E. et al., Vitamin B6 suppresses NF-kappaB activation in LPS-stimulated mouse macrophages. Int. J. Mol. Med. 2005, 16, 1071-1075.
24. Kanouchi, H., Shibuya, M., Tsukamoto, S., Fujimura, Y. et al., Comparisons of uptake and cell surface binding among pyridoxal, pyridoxine, and pyridoxamine in RAW264.7 cells. Nutrition 2010, 26, 648-652.
25. Ghosh, S., May, M. J., Kopp, E. B., NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16, 225-260.
26. Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T., Toriumi, W., IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 1999, 274, 30353-30356.
27. Malek, S., Huxford, T., Ghosh, G., IκBα functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-κB. J. Biol. Chem. 1998, 273, 25427-25436.
28. Tanaka, K., Kawakami, T., Tateishi, K., Yashiroda, H., Chiba, T., Control of IκBα proteolysis by the ubiquitin-proteasome pathway. Biochimie 2001, 83, 351-356.
29. Hill, R. E., Shaw, P. H., Boyd, P. A., Baumann, H., Hastie, N. D., Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions. Nature 1984, 311, 175-177.
30. Ohkubo, K., Ogata, S., Misumi, Y., Takami, N., Ikehara, Y., Molecular cloning and characterization of rat contrapsin-like protease inhibitor and related proteins. J. Biochem. 1991, 109, 243-250.
31. Pages, G., Rouayrenc, J. F., Le Cam, G., Mariller, M., Le Cam, A., Molecular characterization of three rat liver serine-protease inhibitors affected by inflammation and hypophysectomy. Protein and mRNA analysis and cDNA cloning. Eur. J. Biochem. 1990, 190, 385-391.
32. Kordula, T., Bugno, M., Lason, W., Przewlocki, R., Koj, A., Rat contrapsins are the type II acute phase proteins: regulation by interleukin 6 on the mRNA level. Biochem. Biophys. Res. Commun. 1994, 201, 222-227.
33. Takamiya, A., Takeda, M., Yoshida, A., Kiyama, H., Inflammation induces serine protease inhibitor 3 expression in the rat pineal gland. Neuroscience 2002, 113, 387-394.
34. Takamiya, A., Takeda, M., Yoshida, A., Kiyama, H., Expression of serine protease inhibitor 3 in ocular tissues in endotoxin-induced uveitis in rat. Invest. Ophthalmol. Vis. Sci. 2001, 42, 2427-2433.
35. Hershko, A., Ubiquitin: roles in protein modification and breakdown. Cell 1983, 34, 11-12.
36. Xia, Z. P., Sun, L., Chen, X., Pineda, G. et al., Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 2009, 461, 114-119.
37. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M. et al., De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 2004, 430, 694-699.
38. Rodriguez, M. S., Wright, J., Thompson, J., Thomas, D. et al., Identification of lysine residues required for signal-induced ubiquitination and degradation of IκB-α in vivo. Oncogene 1996, 12, 2425-2435.
39. Voutsadakis, I. A., The ubiquitin-proteasome system in colorectal cancer (review). Biochim. Biophys. Acta 2008, 1782, 800-808.
40. Kinzler, K. W., Vogelstein, B., Lessons from hereditary colorectal cancer. Cell 1996, 87, 159-170.
41. Gross-Mesilaty, S., Hargrove, J. L., Ciechanover, A., Degradation of tyrosine aminotransferase (TAT) via the ubiquitin-proteasome pathway. FEBS Lett. 1997, 405, 175-180.